Valley Forge Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-4,100
Closed -$264K 103
2015
Q1
$264K Sell
4,100
-8,980
-69% -$562K 0.03% 86
2014
Q4
$772K Sell
13,080
-770
-6% -$43.4K 0.09% 67
2014
Q3
$709K Sell
13,850
-155,140
-92% -$7.75M 0.09% 70
2014
Q2
$8.2M Sell
168,990
-10,915
-6% -$538K 0.88% 55
2014
Q1
$9.35M Sell
179,905
-204,788
-53% -$10.9M 1.01% 52
2013
Q4
$20.4M Sell
384,693
-367,949
-49% -$18.7M 1.97% 21
2013
Q3
$34.8M Buy
752,642
+10,323
+1% +$453K 2.31% 15
2013
Q2
$33.2M Buy
+742,319
New +$32.2M 2.17% 19

Other funds holding BMY

Valley Forge Asset Management's BMY Position: Q2 2015 in Review

Valley Forge Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 4,100 shares — an estimated $264K sold.

Valley Forge Asset Management first reported a position in BMY in Q2 2013 and held it in 8 quarters. The position peaked at $34.8M in Q3 2013. 1,446 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

  • Valley Forge Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
  • Valley Forge Asset Management sold 4,100 Bristol-Myers Squibb shares in Q2 2015, an estimated $264K.
  • Valley Forge Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 8 quarters.
  • Valley Forge Asset Management's Bristol-Myers Squibb position peaked at $34.8M in Q3 2013.
  • 1,446 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Valley Forge Asset Management's 13F filing for Q2 2015, filed 7 Aug 2015.